Time trends in mobile phone use and glioma incidence among males in the Nordic Countries, 1979–2016
Abstract
INTRODUCTION: In the Nordic countries, the use of mobile phones increased sharply in the mid-1990s especially among middle-aged men. We investigated time trends in glioma incidence rates (IR) with the perspective to inform about the plausibility of brain tumour risks from mobile phone use reported in some case-control studies. METHODS: We analysed IR of glioma in Denmark, Finland, Norway, and Sweden among men aged 40-69 years, using data from national cancer registries and population statistics during 1979-2016, using log-linear joinpoint analysis. Information on regular mobile phone use and amount of call-time was obtained from major studies of mobile phones in these countries. We compared annual observed incidence with that expected under various risk scenarios to assess which of the reported effect sizes are compatible with the observed IR. The expected numbers of cases were computed accounting for an impact of other factors besides mobile phone use, such as improved cancer registration. RESULTS: Based on 18,232 glioma cases, IR increased slightly but steadily with a change of 0.1% (95 %CI 0.0%; 0.3%) per year during 1979-2016 among 40-59-year-old men and for ages 60-69, by 0.6 % (95 %CI 0.4; 0.9) annually. The observed IR trends among men aged 40-59 years were incompatible with risk ratios (RR) 1.08 or higher with a 10-year lag, RR ≥ 1.2 with 15-year lag and RR ≥ 1.5 with 20-year lag. For the age group 60-69 years, corresponding effect sizes RR ≥ 1.4, ≥2 and ≥ 2.5 could be rejected for lag times 10, 15 and 20 years. DISCUSSION: This study confirms and reinforces the conclusions that no changes in glioma incidence in the Nordic countries have occurred that are consistent with a substantial risk attributable to mobile phone use. This particularly applies to virtually all reported risk increases reported by previous case-control studies with positive findings.
Related
- Anti-Glioma Agents and Hyperbaric Oxygen for Prospective Therapeutic Approaches
- Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis
- Single-cell and intercellular communication analyses reveal DLL3 as a key regulator in the glioma tumor microenvironment
- Leucine‐rich glioma inactivated 1 ( LGI1 ) is a ganglioside‐binding protein
- The “mobile bricks” of human evolution: how transposable elements shaped human phenotypes
BibTeX
@article{deltour2026time,
title = {{Time trends in mobile phone use and glioma incidence among males in the Nordic Countries, 1979–2016}},
author = {Isabelle Deltour and Aslak Harbo Poulsen and Christoffer Johansen and Maria Feychting and Tom Børge Johannesen and Anssi Auvinen and Joachim Schüz},
journal = {Environment International},
year = {2026},
month = oct,
doi = {10.1016/j.envint.2022.107487},
url = {https://hal.science/hal-05795606v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Time trends in mobile phone use and glioma incidence among males in the Nordic Countries, 1979–2016
AU - Isabelle Deltour
AU - Aslak Harbo Poulsen
AU - Christoffer Johansen
AU - Maria Feychting
AU - Tom Børge Johannesen
AU - Anssi Auvinen
AU - Joachim Schüz
PY - 2026
DA - 2026/10/12
JO - Environment International
DO - 10.1016/j.envint.2022.107487
UR - https://hal.science/hal-05795606v1
AB - INTRODUCTION: In the Nordic countries, the use of mobile phones increased sharply in the mid-1990s especially among middle-aged men. We investigated time trends in glioma incidence rates (IR) with the perspective to inform about the plausibility of brain tumour risks from mobile phone use reported in some case-control studies. METHODS: We analysed IR of glioma in Denmark, Finland, Norway, and Sweden among men aged 40-69 years, using data from national cancer registries and population statistics during 1979-2016, using log-linear joinpoint analysis. Information on regular mobile phone use and amount of call-time was obtained from major studies of mobile phones in these countries. We compared annual observed incidence with that expected under various risk scenarios to assess which of the reported effect sizes are compatible with the observed IR. The expected numbers of cases were computed accounting for an impact of other factors besides mobile phone use, such as improved cancer registration. RESULTS: Based on 18,232 glioma cases, IR increased slightly but steadily with a change of 0.1% (95 %CI 0.0%; 0.3%) per year during 1979-2016 among 40-59-year-old men and for ages 60-69, by 0.6 % (95 %CI 0.4; 0.9) annually. The observed IR trends among men aged 40-59 years were incompatible with risk ratios (RR) 1.08 or higher with a 10-year lag, RR ≥ 1.2 with 15-year lag and RR ≥ 1.5 with 20-year lag. For the age group 60-69 years, corresponding effect sizes RR ≥ 1.4, ≥2 and ≥ 2.5 could be rejected for lag times 10, 15 and 20 years. DISCUSSION: This study confirms and reinforces the conclusions that no changes in glioma incidence in the Nordic countries have occurred that are consistent with a substantial risk attributable to mobile phone use. This particularly applies to virtually all reported risk increases reported by previous case-control studies with positive findings.
SN - 0160-4120
ER -